KRAS蛋白包含4個(gè)結(jié)構(gòu)域。KRAS蛋白由6條β-折疊鏈和5條-螺旋結(jié)構(gòu)組成，形成兩個(gè)主要結(jié)構(gòu)域：G結(jié)構(gòu)域和C端結(jié)構(gòu)域。

KRAS protein contains 4 domains.KRAS protein is made up of 6 beta-strands and 5 alpha-helicies, which form two major domains: G-domain and C-terminal.

KRAS的G結(jié)構(gòu)域由殘基1-166組成，包括GTP結(jié)合口袋，該區(qū)域?qū)τ谙掠涡?yīng)物和GTPase激活蛋白之間的相互之間作用至關(guān)重要。

The G-domain  of KRAS, comprised of residues 1-166, includes the GTP-binding pocket, a region within which is essential for the interactions between the putative downstream effectors and GTPase-activating proteins.

G結(jié)構(gòu)域是高度保守的，包括負(fù)責(zé)GTP-GTP交換的switch Ⅰ和switch Ⅱ區(qū)域。

The G domain is highly conserved and contains switch Ⅰ and switch Ⅱ loops, which are responsible for GDP-GTP exchange.

C端是一個(gè)包含CAAX基序的高變區(qū)，引導(dǎo)翻譯后修飾并決定細(xì)胞膜錨定，該區(qū)域在RAS蛋白的生物活性調(diào)控中起著重要作用。/p>

The C-terminal, a hypervariable region including the CAAX motif, guides posttranslational modifications and determines plasma membrane anchoring. This region plays an important role in the regulation of the biological activity of RAS protein.

KRAS新藥研發(fā)平臺(tái)

什么是KRAS?

美迪西助力信諾維抗腫瘤1類新藥XNW14010（小分子KRAS G12C蛋白共價(jià)結(jié)合抑制劑）獲批臨床